Insiders at the company have transacted a total of 58 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 25 of these insider trades were purchases, accounting for 200,954 shares. Insider sales of the common stock occurred on 33 occasions, with total insider shares sold totaling 300,108 shares.
The company’s stock has a 5-day price change of -2.12% and -11.61% over the past three months. SLB shares are trading -5.17% year to date (YTD), with the 12-month market performance down to -13.38% lower. It has a 12-month low price of $42.73 and touched a high of $62.12 over the same period. SLB has an average intraday trading volume of 10.19 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.48%, -3.83%, and -7.22% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Schlumberger Ltd. (NYSE: SLB) shares accounts for 83.99% of the company’s 1.43B shares outstanding.
It has a market capitalization of $70.44B and a beta (3y monthly) value of 1.61. The stock’s trailing 12-month PE ratio is 16.95, while the earnings-per-share (ttm) stands at $2.91. The company has a PEG of 0.86 and a Quick Ratio of 1.00 with the debt-to-equity ratio at 0.62. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.36% over the week and 2.47% over the month.
Analysts forecast that Schlumberger Ltd. (SLB) will achieve an EPS of $Albemarle Corporation for the current quarter, $120.31 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $SELLAS Life Sciences Group, Inc while analysts give the company a high EPS estimate of $iShares Silver Trust. Comparatively, EPS for the current quarter was $Standard Lithium Ltd. a year ago. Earnings per share for the fiscal year are expected to increase by 19.68%, and 18.70% over the next financial year. EPS should grow at an annualized rate of 19.70% over the next five years, compared to 13.74% over the past 5-year period.
Looking at the support for the SLB, a number of firms have released research notes about the stock. Societe Generale stated their Buy rating for the stock in a research note on October 09, 2023, with the firm’s price target at $81.
